Trospium
From Wikipedia, the free encyclopedia
|
Trospium
|
|
| Systematic (IUPAC) name | |
| 3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-Spiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium] | |
| Identifiers | |
| CAS number | |
| ATC code | G04 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C25H30NO3 |
| Mol. mass | 392.511 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 50-85% |
| Metabolism | ? |
| Half life | 20 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
'Trospium is a urinary antispasmodic. It is sold under the brand name Sanctura in the US, Trosec in Canada, Regurin in the United Kingdom and Spasmex in Israel.
|
|||||||||||||||||

